These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 8145096
1. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease. Issenman RM, Atkinson SA, Radoja C, Fraher L. J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):401-6. PubMed ID: 8145096 [Abstract] [Full Text] [Related]
2. Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Chesney RW, Mazess RB, Rose P, Jax DK. Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891 [Abstract] [Full Text] [Related]
3. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM. Inflamm Bowel Dis; 2007 Jan; 13(1):42-50. PubMed ID: 17206638 [Abstract] [Full Text] [Related]
4. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Mäkitie O. J Pediatr; 2014 Jun; 164(6):1436-43.e1. PubMed ID: 24650398 [Abstract] [Full Text] [Related]
5. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. Saggese G, Baroncelli GI, Bertelloni S, Perri G. J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269 [Abstract] [Full Text] [Related]
6. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. J Bone Miner Res; 2004 Dec; 19(12):1961-8. PubMed ID: 15537438 [Abstract] [Full Text] [Related]
7. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Cino M, Greenberg GR. Am J Gastroenterol; 2002 Apr; 97(4):915-21. PubMed ID: 12003427 [Abstract] [Full Text] [Related]
8. Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease. Griffin LM, Thayu M, Baldassano RN, DeBoer MD, Zemel BS, Denburg MR, Denson LA, Shults J, Herskovitz R, Long J, Leonard MB. J Clin Endocrinol Metab; 2015 Jul; 100(7):2630-9. PubMed ID: 25919459 [Abstract] [Full Text] [Related]
9. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Scharla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch R, Ziegler R. Exp Clin Endocrinol; 1994 Jul; 102(1):44-9. PubMed ID: 8005208 [Abstract] [Full Text] [Related]
10. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents. Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G. Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973 [Abstract] [Full Text] [Related]
11. Body composition in patients with inflammatory bowel disease: a population-based study. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577 [Abstract] [Full Text] [Related]
12. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy. Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M. Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164 [Abstract] [Full Text] [Related]
13. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942 [Abstract] [Full Text] [Related]
14. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease. Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T. Clin Gastroenterol Hepatol; 2009 Apr; 7(4):452-5. PubMed ID: 19249399 [Abstract] [Full Text] [Related]
15. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276 [Abstract] [Full Text] [Related]
16. Longitudinal monitoring of bone measured by quantitative multisite ultrasound in patients with Crohn's disease. Zadik Z, Sinai T, Zung A, Reifen R. J Clin Gastroenterol; 2005 Feb; 39(2):120-3. PubMed ID: 15681906 [Abstract] [Full Text] [Related]
17. Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. Tuchman S, Thayu M, Shults J, Zemel BS, Burnham JM, Leonard MB. J Pediatr; 2008 Oct; 153(4):484-90. PubMed ID: 18555484 [Abstract] [Full Text] [Related]
18. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT. J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625 [Abstract] [Full Text] [Related]
19. Evaluation of densitometric bone-muscle relationships in Crohn's disease. Mauro M, Armstrong D. Bone; 2007 Jun; 40(6):1610-4. PubMed ID: 17433801 [Abstract] [Full Text] [Related]
20. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease. Navarro FA, Hanauer SB, Kirschner BS. J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743 [Abstract] [Full Text] [Related] Page: [Next] [New Search]